Oberdörster G, Cox C, Gelein R
University of Rochester, Department of Environmental Medicine, School of Medicine and Dentistry, New York, USA.
Exp Lung Res. 1997 Jan-Feb;23(1):17-34. doi: 10.3109/01902149709046045.
Effective elimination of particles deposited in the respiratory tract is an important defense function to protect the organism from potentially adverse effects of inhaled particles. Delivery of radioactively labeled tracer particles and subsequent measurement in vivo of their retention in different regions of the respiratory tract provides an adequate method for characterizing this defensive function. However, the delivery of such tracer particles by inhalation may result in some external contamination of the animals and requires specific protective measures while working with radioactive aerosols. In this study, 85Sr-labeled tracer particles (3 microns) were administered to the lower respiratory tract of rats by intratracheal inhalation to avoid external contamination, and also by intratracheal instillation in order to compare the 2 technique with respect to their suitability for measuring normal and impaired particle clearance rates. It was postulated that particle clearance function in the alveolar region can be determined equally well with intratracheally instilled particles despite their uneven distribution in the lung. For both techniques, rats were anesthesized with halothane and the particles were administered via oral intubation. Retention in the lower respiratory tract of about 30 micrograms (inhalation) and 6 micrograms (instillation) of the administered particles was followed over a period of 180 days by external counting of lung 85Sr-activity in a collimated detection system. To impair alveolar particle clearance rates, groups of rats were subjected to 12 weeks of inhalation exposure prior to delivery of the tracer particles as follows: (1) sham-exposed control; (2) pigment-grade TiO2 particles to induce lung overload: (3) ultrafine TiO2 particles: (4) crystalline SiO2 particles (cristobalite). The following results were obtained: The long-term retention half-times (T1/2) of the tracer particles reflecting alveolar clearance consistently showed the same ranking of the treatment groups whether measured after intratracheal inhalation or instillation. Control values were 66 and 72 days, respectively, and significantly prolonged long-term clearance was measured by both methods for pigment-grade TiO2 (117 and 99 days), ultrafine TiO2 (541 and 600 days) and SiO2 (1901 and 1368 days). Comparison of these values between the two modes of administration of tracer particles showed no significant differences. In contrast, the short-term T1/2 (mucociliary clearance) of the intratracheally instilled tracer particles in the different treatment groups were variable and did not accurately reflect particle clearance from the conducting airways. However, short-term T1/2 after intratracheal inhalation of tracer particles were consistent with fast conducting airway clearance, and mucociliary clearance appears to be stimulated when alveolar clearance is significantly impaired due to particle overload or to effects of cytotoxic particles. The results suggest that intratracheal instillation of a low dose (< or = 10 micrograms) of tracer particles in the rat provides an adequate method for reliably determining effects of inhaled toxicants on alveolar particle clearance function. Further, intratracheal inhalation of tracer particles is useful for measuring both short-term (mucociliary) and long-term (alveolar) particle clearance rates in the lower respiratory tract of the rat.
有效清除沉积在呼吸道中的颗粒是一项重要的防御功能,可保护机体免受吸入颗粒的潜在不利影响。输送放射性标记的示踪颗粒并随后在体内测量其在呼吸道不同区域的滞留情况,为表征这种防御功能提供了一种适当的方法。然而,通过吸入输送此类示踪颗粒可能会导致动物受到一些外部污染,并且在处理放射性气溶胶时需要采取特定的防护措施。在本研究中,通过气管内吸入将85Sr标记的示踪颗粒(3微米)施用于大鼠的下呼吸道以避免外部污染,并且还通过气管内滴注,以便比较这两种技术在测量正常和受损颗粒清除率方面的适用性。据推测,尽管气管内滴注的颗粒在肺内分布不均,但肺泡区域的颗粒清除功能仍可通过这些颗粒很好地确定。对于这两种技术,大鼠均用氟烷麻醉,并通过口腔插管施用颗粒。在准直检测系统中通过外部计数肺85Sr活性,在180天的时间内跟踪约30微克(吸入)和6微克(滴注)施用颗粒在下呼吸道中的滞留情况。为了损害肺泡颗粒清除率,在示踪颗粒输送之前,将大鼠组进行如下12周的吸入暴露:(1)假暴露对照;(2)颜料级TiO2颗粒以诱导肺过载;(3)超细TiO2颗粒;(4)结晶SiO2颗粒(方石英)。获得了以下结果:反映肺泡清除的示踪颗粒的长期滞留半衰期(T1/2),无论在气管内吸入还是滴注后测量,治疗组始终显示相同的排名。对照值分别为66天和72天,两种方法均测量到颜料级TiO2(117天和99天)、超细TiO2(541天和600天)和SiO2(1901天和1368天)的长期清除明显延长。示踪颗粒两种给药方式之间这些值的比较显示无显著差异。相比之下,不同治疗组中气管内滴注的示踪颗粒的短期T1/2(粘液纤毛清除)是可变的,并且不能准确反映颗粒从传导气道的清除情况。然而,气管内吸入示踪颗粒后的短期T1/2与快速的传导气道清除一致,并且当由于颗粒过载或细胞毒性颗粒的作用导致肺泡清除明显受损时,粘液纤毛清除似乎受到刺激。结果表明,在大鼠中气管内滴注低剂量(≤10微克)的示踪颗粒为可靠确定吸入毒物对肺泡颗粒清除功能的影响提供了一种适当的方法。此外,气管内吸入示踪颗粒可用于测量大鼠下呼吸道的短期(粘液纤毛)和长期(肺泡)颗粒清除率。